AdaptHealth (AHCO) Capital Expenditures (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | AdaptHealth | 1.35 Bn | 1.31 Bn | 111.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,196.21% |
| Dec 31, 2025 | 97.70% |
| Sep 30, 2025 | 145.43% |
| Jun 30, 2025 | -98.42% |
| Mar 31, 2025 | 519.48% |
| Dec 31, 2024 | 107.68% |
| Sep 30, 2024 | -250.66% |
| Jun 30, 2024 | -7.53% |
| Mar 31, 2024 | -71.18% |
| Dec 31, 2023 | 66,256.62% |
| Sep 30, 2023 | 76.93% |
| Jun 30, 2023 | -105.72% |
| Mar 31, 2023 | 231.14% |
| Dec 31, 2022 | 74.25% |
| Sep 30, 2022 | -180.75% |
| Jun 30, 2022 | 389.22% |
| Mar 31, 2022 | -58.83% |
| Dec 31, 2021 | -46.79% |
| Sep 30, 2021 | 12,982.28% |
| Jun 30, 2021 | -95.24% |
| Mar 31, 2021 | 13.47% |
| Dec 31, 2020 | 41.97% |
| Sep 30, 2020 | 284.36% |
| Jun 30, 2020 | -60.31% |
| Mar 31, 2020 | -39.19% |
| Dec 31, 2019 | 669.04% |
| Sep 30, 2019 | -141.48% |
| Jun 30, 2019 | 2.74% |